Continuous Production
System.
The future of manufacturing is fast. Intelligent, end-to-end continuous manufacturing coupled with PAT-driven real-time release.
~76%
Reduction in Production Timelines
$150k
Savings via Digital Process Dev
The Building Blocks of Accessible Therapeutics
The average cost of a biological product is 3.7x greater than a small molecule drug. Analysis Zero CPS directly addresses these challenges by combining digital process development, integrated continuous manufacturing, and our PAT system.
- Continuous Integrated Manufacturing: Nested batch integrated manufacturing allows for the continuous flow of material from upstream reactions to fill finish.
- Process Analytical Technologies: Inline process monitoring replaces offline QC testing, eliminating the stop/start gating of traditional batch manufacturing.
- Digital Process Development: High-throughput screening and simulation replace trial-and-error DOE work, accelerating scale-up.
Targeting Single-Day Manufacturing
Built for scalability, Analysis Zero CPS spans from process development runs to GMP-production. This seamless pathway ensures continuity from lab bench to commercial readiness, transforming how advanced therapies are delivered.
Schedule a Demo